KZR
Price
$4.17
Change
+$0.08 (+1.95%)
Updated
Aug 7, 10:32 AM (EDT)
Capitalization
29.95M
SAGE
Price
$8.68
Change
-$0.02 (-0.23%)
Updated
Jul 30 closing price
Capitalization
544.94M
96 days until earnings call
Interact to see
Advertisement

KZR vs SAGE

Header iconKZR vs SAGE Comparison
Open Charts KZR vs SAGEBanner chart's image
Kezar Life Sciences
Price$4.17
Change+$0.08 (+1.95%)
Volume$287
Capitalization29.95M
Sage Therapeutics
Price$8.68
Change-$0.02 (-0.23%)
Volume$22.7M
Capitalization544.94M
KZR vs SAGE Comparison Chart in %
Loading...
KZR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SAGE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
KZR vs. SAGE commentary
Aug 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KZR is a Hold and SAGE is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 07, 2025
Stock price -- (KZR: $4.10 vs. SAGE: $8.68)
Brand notoriety: KZR and SAGE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KZR: 69% vs. SAGE: 421%
Market capitalization -- KZR: $29.95M vs. SAGE: $544.94M
KZR [@Biotechnology] is valued at $29.95M. SAGE’s [@Biotechnology] market capitalization is $544.94M. The market cap for tickers in the [@Biotechnology] industry ranges from $210.97B to $0. The average market capitalization across the [@Biotechnology] industry is $2.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KZR’s FA Score shows that 1 FA rating(s) are green whileSAGE’s FA Score has 1 green FA rating(s).

  • KZR’s FA Score: 1 green, 4 red.
  • SAGE’s FA Score: 1 green, 4 red.
According to our system of comparison, SAGE is a better buy in the long-term than KZR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KZR’s TA Score shows that 3 TA indicator(s) are bullish while SAGE’s TA Score has 4 bullish TA indicator(s).

  • KZR’s TA Score: 3 bullish, 5 bearish.
  • SAGE’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, SAGE is a better buy in the short-term than KZR.

Price Growth

KZR (@Biotechnology) experienced а -5.31% price change this week, while SAGE (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.68%. For the same industry, the average monthly price growth was +9.93%, and the average quarterly price growth was +14.10%.

Reported Earning Dates

SAGE is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Biotechnology (+2.68% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SAGE($545M) has a higher market cap than KZR($30M). SAGE YTD gains are higher at: 59.853 vs. KZR (-38.988). KZR has higher annual earnings (EBITDA): -76.06M vs. SAGE (-358.98M). SAGE has more cash in the bank: 424M vs. KZR (114M). SAGE has less debt than KZR: SAGE (11.9M) vs KZR (14.1M). SAGE has higher revenues than KZR: SAGE (47.4M) vs KZR (0).
KZRSAGEKZR / SAGE
Capitalization30M545M6%
EBITDA-76.06M-358.98M21%
Gain YTD-38.98859.853-65%
P/E RatioN/AN/A-
Revenue047.4M-
Total Cash114M424M27%
Total Debt14.1M11.9M118%
FUNDAMENTALS RATINGS
KZR vs SAGE: Fundamental Ratings
KZR
SAGE
OUTLOOK RATING
1..100
5718
VALUATION
overvalued / fair valued / undervalued
1..100
12
Undervalued
31
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9798
PRICE GROWTH RATING
1..100
8449
P/E GROWTH RATING
1..100
10097
SEASONALITY SCORE
1..100
4350

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

KZR's Valuation (12) in the Biotechnology industry is in the same range as SAGE (31) in the Pharmaceuticals Other industry. This means that KZR’s stock grew similarly to SAGE’s over the last 12 months.

KZR's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as SAGE (100) in the Pharmaceuticals Other industry. This means that KZR’s stock grew similarly to SAGE’s over the last 12 months.

KZR's SMR Rating (97) in the Biotechnology industry is in the same range as SAGE (98) in the Pharmaceuticals Other industry. This means that KZR’s stock grew similarly to SAGE’s over the last 12 months.

SAGE's Price Growth Rating (49) in the Pharmaceuticals Other industry is somewhat better than the same rating for KZR (84) in the Biotechnology industry. This means that SAGE’s stock grew somewhat faster than KZR’s over the last 12 months.

SAGE's P/E Growth Rating (97) in the Pharmaceuticals Other industry is in the same range as KZR (100) in the Biotechnology industry. This means that SAGE’s stock grew similarly to KZR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
KZRSAGE
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
77%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
77%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
83%
MACD
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
80%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
73%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
83%
Advances
ODDS (%)
Bullish Trend 24 days ago
74%
Bullish Trend 28 days ago
77%
Declines
ODDS (%)
Bearish Trend 7 days ago
89%
Bearish Trend 9 days ago
81%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
70%
Aroon
ODDS (%)
N/A
Bullish Trend 1 day ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
KZR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SAGE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BMDSX20.72N/A
N/A
Baird Mid Cap Growth Investor
ASCQX16.60N/A
N/A
American Century Small Company I
ODIIX130.68N/A
N/A
Invesco Discovery R6
FGIWX12.95N/A
N/A
Nuveen Global Infrastructure R6
UIVCX12.50N/A
N/A
MFS Intrinsic Value C

KZR and

Correlation & Price change

A.I.dvisor indicates that over the last year, KZR has been loosely correlated with AMRN. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if KZR jumps, then AMRN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KZR
1D Price
Change %
KZR100%
+0.74%
AMRN - KZR
56%
Loosely correlated
-0.53%
CNTB - KZR
47%
Loosely correlated
-3.18%
SAGE - KZR
36%
Loosely correlated
N/A
RAPT - KZR
34%
Loosely correlated
-1.09%
CTMX - KZR
34%
Loosely correlated
-8.44%
More